Enbridge Short-Term Borrowings decreased by 19.2% to $1.03B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 94.7%, from $529.00M to $1.03B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows relatively stable performance with a -1.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.41B | $1.21B | $1.52B | $1.60B | $1.62B | $1.88B | $2.00B | $1.44B | $848.00M | $1.58B | $400.00M | $335.00M | $200.00M | $928.00M | $529.00M | $859.00M | $914.00M | $1.27B | $1.03B |
| QoQ Change | — | -14.5% | +25.7% | +5.9% | +1.0% | +16.2% | +6.1% | -28.0% | -41.0% | +86.8% | -74.7% | -16.3% | -40.3% | +364.0% | -43.0% | +62.4% | +6.4% | +39.4% | -19.2% |
| YoY Change | — | — | — | — | +14.9% | +56.2% | +31.7% | -10.4% | -47.7% | -15.8% | -80.0% | -76.7% | -76.4% | -41.4% | +32.3% | +156.4% | +357.0% | +37.3% | +94.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.